Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline for severe ischemic stroke
IRCT20190311043008N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hypertonic saline and Normal Saline-Benha University in ischemic stroke (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Hospital death, Duration of hospitalization and 2 more. Started Nov 2020; status: completed.
02
Drugs
hypertonic salineNormal Saline-Benha University
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20190311043008N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190311043008N1.